Leishmania infantum: Lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 8, 1998, Pages 2141-2143

  Durand, Remy ^a,c   Paul, Muriel ^a   Pratlong, Francine ^b   Rivollet, Daniele ^a   Dubreuil Lemaire, Marie Laure ^a   Houin, Rene ^a   Astier, Alain ^a   Deniau, Michele ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b Lab d'Ecolgie Med Pathol P   (France)

^c Faculty of Medecine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEISHMANIA INFANTUM; LIVER CELL NUCLEUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT FAILURE; VISCERAL LEISHMANIASIS;

EID: 0031903651     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.8.2141     Document Type: Article

References (16)

1. Alvar, J., C. Canavate, B. Gutierrez-Solar, M. Jimenez, F. Laguna, R. Lopez-Velez, R. Molina, and J. Moreno. 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin. Microbiol. Rev. 10:298-319.
2. Bryceson, A. D. M., J. D. Chulay, M. Ho, M. Mugambii, J. B. Were, R. Muigal, C. Chunge, G. Gachihi, J. Meme, G. Anabwani, and S. M. Bhatt. 1985. Visceral leishmaniasis unresponsive to antimonial drugs. I. Clinical and immunological studies. Trans. R. Soc. Trop. Med. Hyg. 79:700-704.
3. Davidson, R. N., L. Di Martino, L. Gradoni, R. Giacchino, R. Russo, G. B. Gaeta, R. Pempinello, S. Scotti, F. Raimondi, A. Cascio, T. Prestileo, L. Caldeira, R. J. Wilkinson, and A. D. M. Bryceson. 1994. Liposomal amphotericin B (Ambisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Q. J. Med. 87:75-81.
4. Davidson, R. N., L. Di Martino, L. Gradoni, R. Giacchino, G. B. Gaeta, R. Pempinello, S. Scotti, A. Cascio, E. Castagnola, A. Maisto, M. Gramiccia, D. Di Caprio, R. J. Wilkinson, and A. D. M. Bryceson. 1996. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (Ambisome). Clin. Infect. Dis. 22:938-943.
5. Faraut-Gambarelli, F., R. Piarroux, M. Deniau, B. Giusiano, P. Marty, G. Michel, B. Faugère, and H. Dumon. 1997. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob. Agents Chemother. 41:827-830.
6. Matheron, S., A. Cabie, F. Parquin, C. Mayaud, P. Roux, M. Antoine, R. Chougnet, and J. P. Coulaud. 1992. Visceral leishmaniasis in HIV infection: unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis. AIDS 6:238-240. (Letter.)
7. Paul, M., R. Durand, H. Fessi, D. Rivollet, R. Houin, A. Astier, and M. Deniau. 1997. Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model. Antimicrob. Agents Chemother. 41:1731-1734.
8. Peters, B. S., D. Fish, R. Golden, D. A. Evans, A. D. M. Bryceson, and A. J. Pinching. 1990. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q. J. Med. 77:1101-1111.
9. Pratlong, F., J. P. Dedet, P. Marty, M. Portus, M. Deniau, J. Dereure, P. Abranches, J. Reynes, A. Martini, M. Lefebvre, and J. A. Rioux. 1995. Leishmania-human immunodeficiency virus coinfections in the Mediterranean basin: isoenzymatic characterisation of 100 isolates of the Leishmania infantum complex. J. Infect. Dis. 172:323-326.
10. Rioux, J. A., G. Moreno, G. Lanotte, F. Pratlong, J. Dereure, and P. Rispail. 1986. Two episodes of cutaneous leishmaniasis in man caused by different zymodemes of Leishmania infantum s.l. Trans. R. Soc. Trop. Med. Hyg. 80: 1004-1005.
11. Rioux, J. A., G. Lanotte, E. Serres, F. Pratlong, P. Bastien, and J. Perrieres. 1990. Taxonomy of Leishmania. Use of isoenzymes. Suggestion for a new classification. Ann. Parasitol. Hum. Comp. 65:111-125.
12. Russo, R., L. C. Nigro, S. Minniti, A. Montineri, L. Gradoni, L. Caldeira, and R. N. Davidson. 1996. Visceral leishmaniasis in HIV-infected patients: treatment with high dose liposomal amphotericin B (Ambisome). J. Infect. 32:133-137.
13. Stauber, L. A., E. M. Franchino, and J. Grun. 1958. An eight-day method for screening compounds against Leishmania donovani in golden hamster. J. Protozool. 5:269-273.
14. Sulahian, A., Y. J. F. Garin, F. Pratlong, J. P. Dedet, and F. Derouin. 1997. Experimental pathogeny of viscerotropic and dermotropic isolates of Leishmania infantum from immunocompromised and immunocompetent patients in a murine model. FEMS Immunol. Med. Microbiol. 17:131-138.
15. Thakur, C. P., M. Kumar, and A. K. Pandey. 1991. Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study. Am. J. Trop. Med. Hyg. 45:435-441.
16. Torre-Cisneros, J., J. L. Villanueva, J. M. Kindelan, R. Jurado, and P. Sanchez-Guijo. 1993. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 17:625-627.